Skip to main content
. 2011 Feb 18;46(1):119–151. doi: 10.1080/00273171.2011.540480

TABLE 2.

Baseline Characteristics of Treated and Untreated Participants in the First Propensity Score Matched Sample

Variable No Smoking Cessation Counseling (N = 682) Smoking Cessation Counseling (N = 682) Standardized Difference of the Mean Variance Ratio
Demographic Characteristics
Age 59.3 ± 11.8 59.5 ± 13.1 0.012 1.235
Female 176 (25.8%) 188 (27.6%) 0.040 1.043

Presenting Signs and Symptoms
Acute pulmonary edema 28 (4.1%) 29 (4.3%) 0.007 1.034

Vital Signs on Admission
Systolic blood pressure 148.8 ± 31.2 147.7 ± 31.2 0.036 1.002
Diastolic blood pressure 86.4 ± 18.9 85.7 ± 18.5 0.036 0.952
Heart rate 83.2 ± 24.4 82.5 ± 21.9 0.029 0.808
Respiratory rate 20.9 ± 5.3 21.0 ± 5.7 0.027 1.130

Classic Cardiac Risk Factors
Diabetes 149 (21.8%) 148 (21.7%) 0.004 0.995
Hyperlipidemia 217 (31.8%) 218 (32.0%) 0.003 1.002
Hypertension 276 (40.5%) 260 (38.1%) 0.048 0.979
Family history of coronary artery disease 229 (33.6%) 244 (35.8%) 0.046 1.030

Comorbid Conditions and Vascular History
Cerebrovascular accident/Transient ischemic attack 47 (6.9%) 45 (6.6%) 0.012 0.960
Angina 174 (25.5%) 174 (25.5%) 0.000 1.000
Cancer 15 (2.2%) 14 (2.1%) 0.010 0.935
Dementia 6 (0.9%) 9 (1.3%) 0.042 1.493
Previous myocardial infarction 143 (21.0%) 138 (20.2%) 0.018 0.974
Asthma 42 (6.2%) 35 (5.1%) 0.044 0.842
Depression 64 (9.4%) 64 (9.4%) 0.000 1.000
Peptic ulcer disease 36 (5.3%) 35 (5.1%) 0.007 0.974
Peripheral vascular disease 64 (9.4%) 54 (7.9%) 0.052 0.857
Previous coronary revascularization 45 (6.6%) 45 (6.6%) 0.000 1.000
Chronic congestive heart failure 20 (2.9%) 14 (2.1%) 0.056 0.706

Laboratory Tests
Glucose 9.1 ± 5.4 9.2 ± 5.6 0.019 1.095
White blood count 10.7 ±i 3.8 10.8 ± 4.1 0.024 1.154
Hemoglobin 144.2 ± 16.4 143.1 ± 18.4 0.064 1.249
Sodium 139.0 ± 3.4 139.0 ± 3.9 0.002 1.364
Potassium 4.1 ± 0.5 4.1 ± 0.5 0.014 1.166
Creatinine 93.2 ± 38.3 93.2 ± 43.9 0.001 1.310

Prescriptions for Cardiovascular Medications at Hospital Discharge
Statin 184 (27.0%) 188 (27.6%) 0.013 1.014
Beta-blocker 425 (62.3%) 437 (64.1%) 0.036 0.980
Angiotensin Converting Enzyme (ACE) inhibitor/Angiotensin receptor blockers 335 (49.1%) 322 (47.2%) 0.038 0.997
Plavix 30 (4.4%) 29 (4.3%) 0.007 0.968
Acetylsalicyclic Acid (ASA) 513 (75.2%) 514 (75.4%) 0.003 0.996

Note. Continuous variables are presented as means ± standard deviation; dichotomous variables are presented as N (%).